Quality of Life Outcomes from a Dose-per-Fraction Escalation Trial of Hypofractionation in Prostate Cancer

OBJECTIVE: This multi-institutional phase I/II trial explored patient-assessed tolerance of increasingly hypofractionated (HPFX) radiation for low/intermediate risk prostate cancer. METHODS: 347 patients enrolled from 2002–2010. Three increasing dose-per-fraction schedules of 64.7 Gy/22 fx, 58.08 Gy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiother Oncol
Main Authors: Brower, Jeffrey V, Forman, Jeffrey D, Kupelian, Patrick A, Petereit, Daniel G, Gondi, Vinai, Lawton, Colleen A, Anger, Nick, Saha, Sandeep, Chappell, Rick, Ritter, Mark A
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4764419/
https://ncbi.nlm.nih.gov/pubmed/26755165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2015.12.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados